Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis-Mediated Pulmonary Arterial Vascular Remodeling

Hypoxic pulmonary hypertension (HPH) lacks effective treatments. The research is designed to examine the effectiveness of Notoginsenoside R1 (NGR1) in addressing HPH and to explore its molecular mechanisms. Under hypoxic conditions, we created a rat model of HPH and treated the animals with NGR1. We...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xiaowei Gong, Yanling Sheng, Gaijun Zhang, Shiwei Kang, Xin Liu, Yuming Wang, Tao Zhang, Hanzhou Li, Huan Pei, Yadong Yuan, Feitian Min, Huantian Cui
Format: Artigo
Jezik:Inglês
Izdano: Wiley 2025-01-01
Serija:Canadian Respiratory Journal
Online pristup:http://dx.doi.org/10.1155/carj/2884885
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items